122 related articles for article (PubMed ID: 24977484)
1. PS dependent APP cleavage regulates glucosylceramide synthase and is affected in Alzheimer's disease.
Grimm MO; Hundsdörfer B; Grösgen S; Mett J; Zimmer VC; Stahlmann CP; Haupenthal VJ; Rothhaar TL; Lehmann J; Pätzold A; Zinser EG; Tanila H; Shen J; Müller U; Grimm HS; Hartmann T
Cell Physiol Biochem; 2014; 34(1):92-110. PubMed ID: 24977484
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.
Grimm MO; Zinser EG; Grösgen S; Hundsdörfer B; Rothhaar TL; Burg VK; Kaestner L; Bayer TA; Lipp P; Müller U; Grimm HS; Hartmann T
PLoS One; 2012; 7(3):e34095. PubMed ID: 22470521
[TBL] [Abstract][Full Text] [Related]
3. Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression.
Zhang YW; Wang R; Liu Q; Zhang H; Liao FF; Xu H
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10613-8. PubMed ID: 17556541
[TBL] [Abstract][Full Text] [Related]
4. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.
Shen J; Kelleher RJ
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):403-9. PubMed ID: 17197420
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
7. Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo.
Gunawardena S; Yang G; Goldstein LS
Hum Mol Genet; 2013 Oct; 22(19):3828-43. PubMed ID: 23710041
[TBL] [Abstract][Full Text] [Related]
8. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
10. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
11. Dictyostelium possesses highly diverged presenilin/gamma-secretase that regulates growth and cell-fate specification and can accurately process human APP: a system for functional studies of the presenilin/gamma-secretase complex.
McMains VC; Myre M; Kreppel L; Kimmel AR
Dis Model Mech; 2010; 3(9-10):581-94. PubMed ID: 20699477
[TBL] [Abstract][Full Text] [Related]
12. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
13. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
[TBL] [Abstract][Full Text] [Related]
14. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.
Ariga T; Itokazu Y; McDonald MP; Hirabayashi Y; Ando S; Yu RK
ASN Neuro; 2013 May; 5(2):141-8. PubMed ID: 23565921
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease.
Wang BJ; Her GM; Hu MK; Chen YW; Tung YT; Wu PY; Hsu WM; Lee H; Jin LW; Hwang SL; Chen RP; Huang CJ; Liao YF
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3129-E3138. PubMed ID: 28351972
[TBL] [Abstract][Full Text] [Related]
16. High content analysis of gamma-secretase activity reveals variable dominance of presenilin mutations linked to familial Alzheimer's disease.
Florean C; Zampese E; Zanese M; Brunello L; Ichas F; De Giorgi F; Pizzo P
Biochim Biophys Acta; 2008 Aug; 1783(8):1551-60. PubMed ID: 18424271
[TBL] [Abstract][Full Text] [Related]
17. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
18. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
19. Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice.
Choudhry F; Howlett DR; Richardson JC; Francis PT; Williams RJ
Neurobiol Aging; 2012 May; 33(5):960-8. PubMed ID: 20724034
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
